ERCC3 and Miyoshi myopathy: Conversely, compound SCR7, via inhibition of enzymes involved in NER (including ERCC excision repair 3, TFIIH core complex helicase subunit-ERCC3/XPB or XPC complex subunit, DNA damage recognition and repair factor-XPC), sensitizes MM cells to melphalan treatment [48,49].